American Medical Technologies Announces Intent to Acquire Spectrum Dental Inc.

CORPUS CHRISTI, Texas -- American Medical Technologies, Inc. ("AMT" or the "Company") (OTCBB:ADLI) today announced it is in final discussions to purchase Spectrum Dental, Inc. for three million shares of AMT's common stock and $500,000.

Spectrum Dental markets its products to professional dental customers in the United States and around the world via a wholesale distribution system that includes major dental supply companies such as Henry Schein and Patterson Dental. Founded in 1994 as Interdent Inc., Spectrum Dental changed its name to Spectrum Dental, Inc. in 1999.

Spectrum Dental is a provider of professional tooth whitening products under the brand names Contrastpm(R), Contrastpm(R)plus and Contrastam(R).

"We are excited about the growth opportunities associated with this transaction," stated Roger W. Dartt, President and CEO of AMT. "The addition of an established brand tooth whitening product line to augment our current Hydrobrasion(TM) product line, highlighted by our Hydro Jet(R) products, will provide AMT with a complementary line of high-technology, high-quality products for the general dentistry market."

As part of the agreement, AMT will sign a manufacturing agreement with Westside Packaging Inc., the current manufacturer of the Spectrum Dental line, to continue manufacturing the Spectrum Dental product line for AMT.

AMT also announced that as part of the same transaction, AMT will sell its 45,000 square-foot Corpus Christi facility for $1.9 million to the Sepulveda Group LLC, and lease it back for five years.

AMT develops, manufactures and markets high-technology Hydrobrasion products designed primarily for general dentistry that are a dramatic alternative to the shot and drill. AMT's patented Hydrobrasion products provide dentists with a minimally invasive process that safely removes dental tooth structure and tooth decay by means of a slurry composed of air, water and micro particles. The Hydrobrasion technology and recently introduced Hydro Jet product line lessens patient sensitivity and may be used to treat a patient without anesthesia. The Company's securities are quoted on the OTC Bulletin Board under the symbol ADLI, and its website is at www.americanmedicaltech.com.

The Company makes forward-looking statements in this press release and in its filings with the Securities and Exchange Commission. The Company's forward-looking statements are subject to risks and uncertainties and include information about its expectations and possible or assumed future results of operations. When the Company uses any of the words "believes," "expects," "anticipates," "estimates" or similar expressions, it is making forward-looking statements.

To the extent available to it, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 for all of its forward-looking statements. While the Company believes that its forward-looking statements are reasonable, you should not place undue reliance on any such forward-looking statements, which speak only as of the date made. Because these forward-looking statements are based on estimates and assumptions that are subject to significant business, economic and competitive uncertainties, many of which are beyond the Company's control or are subject to change, actual results could be materially different. Factors that might cause such a difference include, without limitation, the following: the Company's inability to generate sufficient cash flow to meet its current liabilities, the Company's potential inability to hire and retain qualified sales and service personnel, the potential for an extended decline in sales, the possible failure of revenues to offset additional costs associated with its change in business model, the potential lack of product acceptance, the Company's potential inability to introduce new products to the market, the potential failure of customers to meet purchase commitments, the potential loss of customer relationships, the potential failure to receive or maintain necessary regulatory approvals, the extent to which competition may negatively affect prices and sales volumes or necessitate increased sales expenses, and the other risks and uncertainties.

Other factors not currently anticipated by management may also materially and adversely affect the Company's results of operations. Except as required by applicable law, the Company does not undertake any obligation to publicly release any revisions which may be made to any forward-looking statements to reflect events or circumstances occurring after the date of this report.